Both in Pharmaceuticals
Milestone Pharmaceuticals vs Genelux
Over the past year MIST returned −61.0% and GNLX returned −75.7%; their daily moves had a correlation of 0.25.
MIST −61.0% GNLX −75.7%Growth of $1, one year, split-adjusted
| Metric | MIST | GNLX |
|---|---|---|
| Price | $0.7211 | $2.00 |
| Market cap | $89.8M | $90.5M |
| Today | −1.22% | −3.85% |
| 1 month | −10.9% | −21.9% |
| 6 months | −61.9% | −29.8% |
| Year to date | −64.3% | −54.1% |
| 1 year | −61.6% | −74.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 94.3% | — |
| Net margin | −5118.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 38.3× | 11,311.3× |
| Net cash | $111.4M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 73.5% | 65.6% |
| Short % of float | 17.9% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).